X
Software Functionality Revealed in Detail
We’ve opened the hood on every major category of enterprise software. Learn about thousands of features and functions, and how enterprise software really works.
Get free sample report

Compare Software Solutions
Visit the TEC store to compare leading software solutions by funtionality, so that you can make accurate and informed software purchasing decisions.
Compare Now
 

 j d adward


Is J. D. Edwards’ xtr@ Ordinary?
J. D. Edwards’ supply chain messaging architecture may make life easier for xtr@ users, but offers questionable benefits for collaboration partners.

j d adward  J. D. Edwards’ xtr@ Ordinary? Is J. D. Edwards' xtr@ Ordinary? S. McVey - April 24th, 2000 Event Summary Last month in Las Vegas, IBM convened a meeting of executives to discuss current trends in today's digital marketplace and best practices for success. The IBM Supply Chain Executive Conference provided forums for participants from the user community and featured presentations by vendors and partners. Michael Schmitt, senior vice president of B2B e-commerce at J. D. Edwards & Company, spoke on

Read More


Software Functionality Revealed in Detail

We’ve opened the hood on every major category of enterprise software. Learn about thousands of features and functions, and how enterprise software really works.

Get free sample report
Compare Software Solutions

Visit the TEC store to compare leading software by functionality, so that you can make accurate and informed software purchasing decisions.

Compare Now

Documents related to » j d adward

J.D. Edwards and Numetrix Ponder the Future as One


Deciding that acquisition is the better part of valor, Numetrix cancelled its IPO to combine fortunes with ERP vendor J. D. Edwards & Company. Though technologically adept in the areas of supply chain planning and optimization, Numetrix has lacked a successful marketing strategy, a primary factor in its demise as an independent company. Now, the marketplace scrutinizes the new combination, strategies for integration of Numetrix, and the growing footprint of J. D. Edwards.

j d adward   Read More

What Have Epicor and Activant Been Up To (Post-Merger)?


April 2011 saw the merger of Epicor and Activant Solutions to create a global leader in business software solutions. TEC principal analyst P. J. Jakovljevic sits down with CMO John Hiraoka to discuss the opportunities and challenges created by the merger and the potential synergy of the combined company, Epicor Software Corporation, to grow a wide range of products and industries, a very ambitious yet difficult-to-realize strategy.

j d adward   Read More

Retalix


Within the store, Retalix provides a tightly integrated suite of products that include point of sale (POS), fuel, back-office, vendor receiving, loyalty program, self-service checkout, wireless hand-held solutions, and Web-based reporting functionality. At the headquarters, Retalix provides host functionality for grocery retailers to manage and gain insight into price and item management, with the ability to develop and deliver targeted customer promotions. In the Warehouse, Retalix provides a feature-rich inbound and outbound solution with voice-picking capabilities.  

j d adward   Read More

i2 Technologies’ Latest Offering: J. D. Edwards OneWorld™


Users should welcome the prospects for better integration delivered by the new alliance but temper expectations with the realization that it may be merely a political move.

j d adward   Read More

Source Code Translation


Everyone who writes computer software eventually faces the requirement of converting a large code base from one programming language to another. But source-code conversion is a tedious, error-prone, and labor-intensive process. While there is no magic button to turn old code into new code, there are tools that can dramatically reduce the time and cost of a conversion project. Find out more.

j d adward   Read More

Managing the Aches and Pains of Long Cycle Times: Automating Controls for Pharmaceutical Manufacturers


One of the biggest challenges (or business pain points) for pharmaceutical manufacturers (or life sciences companies) is the long cycles that are required for research and development (R@D) and product approval. This is particularly a challenge for manufacturers of generic drugs, for which cycle times can average 20 months or more (and the full time-to-market period upwards of 12 years). Why

j d adward   Read More

J-Squared Technologies Inc.


J-Squared has 20+ years design experience with OEMs and system builders serving a broad base of markets including Industrial, Transportation, Medical, Communications and Military. At J-Squared we believe: We need to facilitate the collaboration required to enable the alignment of our customer's purchasing, operations and engineering departments to ensure the best decisions are made for all organizations. Our customer has the right to sound technical advice and support. Our customer has the right to proper logistics support.  

j d adward   Read More

Enabling Growth and Transformation in Pharmaceutical and Biotech R&D


Whether you’re a niche-market start-up developing a single compound or a well-established global company with dozens of projects in the pipeline, the pressure to innovate in the life sciences industry is unrelenting. That’s why you need a solution that can help monitor resources, prioritize projects, optimize the clinical trial supply chain, and maximize the overall value of your product portfolio.

j d adward   Read More

PeopleSoft's Buying Momentum Goes On. Pageant Participants, Line Up Please! Part 2: User Recommendations


Having stashed almost $1.7 billion in cash, PeopleSoft’s thirst does not seem to be quenched by the recent buy-back of Momentum Business Applications, an R&D firm it created and spun off in 1998. While the speculations about the next acquisition candidate abound, many supply chain companies have been dolling themselves up hoping to catch one of the most eligible bachelor’s eye.

j d adward   Read More

Lilly Software - Product Enhancements Remain Its Order 'Du Jour' Part Two: Market Impact


Lilly continues to invest uncompromisingly in R&D, and consequently espouses a convincing broad but compact product portfolio for its target market.

j d adward   Read More